亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

上海西睿化工有限公司  

公司主要生產并銷售核苷酸,糖類衍生物和氨基酸衍生物。

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:歐陽百川
  • 電話:021-61553265
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 西睿化工供應克羅拉濱(氯法拉濱)中間體6974-32-9
西睿化工供應克羅拉濱(氯法拉濱)中間體6974-32-9
單價 面議對比
詢價 暫無
發貨 上海付款后3天內
品牌 西睿化工
過期 長期有效
更新 2015-10-28 16:32
 
詳細信息
 Cas:6974-32-9

中文名稱: 1-乙酰-2,3,5-三苯甲酰-1-β-D-呋喃核糖
 
中文別名: 克羅拉濱中間體; 1-乙酰基-2,3,5-三苯甲酰基-β-D-呋喃核糖; 1鄰乙酰-2,3,5-三鄰芐酰基-~-D-呋喃核糖; 氯法拉濱中間體2  
英文名稱: Beta-D-Ribofuranose 1-acetate 2,3,5-tribenzoate  
英文別名: 1-O-Acetyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranose; ?D-Ribofuranose 1-acetate 2,3,5-tribenzoate; Clofarabine intermediate (II); β-D-Ribofuranose, 1-acetate 2,3,5-tribenzoate;  
EINECS:  
分 子 式: C28H24O9  
分 子 量: 504.49 

物理化學性質

熔點 128-130 ºC
比旋光度 24.4 º (C=1, PYRIDINE)

©2025 上海西睿化工有限公司 版權所有   技術支持:化工網   訪問量:3278  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |